Flare Risk Increases When Medication Is Stopped Prior to Arthroplasty

One other interesting aspect of the study, according to Dr. Goodman, is that it has permitted the clinician group to collaborate with basic science researchers to study the target tissue in RA.

Vanessa Caceres is a medical writer in Bradenton, Fla.

Reference

1. Goodman SM, Bykerk VP, DiCarlo E, et al. Flares in patients with rheumatoid arthritis after total hip and total knee arthroplasty: Rates, characteristics, and risk factors. J Rheumatol. 2018 May;45(5):604–611.
2. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008 Jun 15;59(6):762–784.
3. Goodman SM, Springer B, Guyatt G, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or knee arthroplasty. J Arthroplasty. 2017 Sep;32(9):2828–2838.